Clinical efficacy and safety of Shensong Yangxin capsule-antiarrhythmic drug combination for paroxysmal atrial fibrillation: A meta-analysis of randomized controlled trials
Xinfu Cao(Nanjing University of Chinese Medicine), Xiaolong Li(People 's Liberation Army 451 Hospital), Zhenhua Gu(Nanjing University of Chinese Medicine), Yi Sun(Nanjing University of Chinese Medicine), Hongwen Yu(Gaochun People's Hospital), Yuqiao Chen(Central South University), Chao Tang(North Sichuan Medical University)
Cited by 2
Related Papers
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
|Cell Host & Microbe|2021|140
Risk Factors for Rebleeding of Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis
|PLoS ONE|2014|129
Real-time detection of 20 amino acids and discrimination of pathologically relevant peptides with functionalized nanopore
|Nature Methods|2024|122
Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
|Cancer Immunology Immunotherapy|2018|111